Colgate-Palmolive (NYSE:CL) Shares Bought by Barclays PLC

Barclays PLC lifted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 38.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,644,189 shares of the company's stock after purchasing an additional 2,132,747 shares during the quarter. Barclays PLC owned about 0.94% of Colgate-Palmolive worth $793,542,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. RFG Advisory LLC raised its stake in shares of Colgate-Palmolive by 2.1% during the 2nd quarter. RFG Advisory LLC now owns 5,411 shares of the company's stock worth $525,000 after buying an additional 112 shares in the last quarter. Occidental Asset Management LLC boosted its position in shares of Colgate-Palmolive by 7.7% during the 2nd quarter. Occidental Asset Management LLC now owns 2,860 shares of the company's stock worth $278,000 after purchasing an additional 205 shares in the last quarter. LVW Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth $281,000. Sequoia Financial Advisors LLC increased its holdings in shares of Colgate-Palmolive by 3.9% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 20,279 shares of the company's stock valued at $1,968,000 after purchasing an additional 767 shares in the last quarter. Finally, Wedmont Private Capital lifted its stake in shares of Colgate-Palmolive by 17.4% in the second quarter. Wedmont Private Capital now owns 6,943 shares of the company's stock valued at $681,000 after purchasing an additional 1,027 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.37% of the company's stock.

Colgate-Palmolive Trading Down 1.4 %

Shares of Colgate-Palmolive stock traded down $1.28 during trading hours on Monday, hitting $92.95. The company's stock had a trading volume of 4,933,592 shares, compared to its average volume of 4,384,197. The business has a fifty day moving average of $96.54 and a 200 day moving average of $98.66. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The company has a market capitalization of $75.94 billion, a PE ratio of 27.00, a P/E/G ratio of 3.36 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's payout ratio is 57.31%.

Wall Street Analyst Weigh In

Several analysts have weighed in on CL shares. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a report on Monday, October 28th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their target price for the company from $105.00 to $101.00 in a report on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, October 28th. Finally, JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.